Use of prednisone for choroidal detachment after trabeculectomy

ISRCTN ISRCTN15966680
DOI https://doi.org/10.1186/ISRCTN15966680
Secondary identifying numbers 0745/02
Submission date
14/10/2008
Registration date
30/10/2008
Last edited
30/10/2008
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Eye Diseases
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr Augusto Paranhos
Scientific

Federal University of Sao Paulo
Botucatu, 824
Sao Paulo
04023-062
Brazil

Email augusto.paranhos@uol.com.br

Study information

Study designDouble-masked randomised controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeTreatment
Scientific titleUse of prednisone for choroidal detachment after trabeculectomy: a double-masked randomised controlled trial
Study objectivesTo evaluate the treatment with oral prednisone for choroidal detachment after trabeculectomy.
Ethics approval(s)The Ethics Committee of the Federal University of Sao Paulo gave approval on the 27th November 2002.
Health condition(s) or problem(s) studiedChoroidal detachment after trabeculectomy
InterventionOral prednisone 1 mg/kg daily for 7 days followed by a progressive reduction of 10 mg every 7 days. Patients in the placebo group received similar capsules containing starch for the same duration as the intervention group. Duration of the treatment ranged from 4 to 7 weeks.
Intervention typeDrug
Pharmaceutical study type(s)
PhaseNot Specified
Drug / device / biological / vaccine name(s)Prednisone
Primary outcome measureChoroidal detachment resolution. Indirect ophthalmoscopy and ocular ultrasonography (B-mode) were performed weekly to evaluate the choroidal detachment until total reattachment of the choroid. The main outcome measure was the time elapsed between the detection of detachment and total reattachment of the choroid.
Secondary outcome measuresIntra-ocular pressure, evaluated every 5 days.
Overall study start date01/02/2003
Completion date01/12/2005

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit18 Years
SexBoth
Target number of participants40
Key inclusion criteria1. Both males and females, older then 18 years old
2. Primary open or narrow angle glaucoma submitted to trabeculectomy that developed choroidal detachment
3. Choroidal detachment should be diagnosed during the first two weeks after surgery
4. Choroidal detachment should be exudative by ultra-sound
Key exclusion criteria1. Other acute ocular disease
2. Positive Seidel test
3. Choroidal kissing
4. Athalamia
5. Clinical uncontrolled diabetes mellitus or systemic arterial hypertension
6. Hypersensitivity for any of the drugs components on the trial
7. Psychiatric disease
8. Pregnancy
Date of first enrolment01/02/2003
Date of final enrolment01/12/2005

Locations

Countries of recruitment

  • Brazil

Study participating centre

Federal University of Sao Paulo
Sao Paulo
04023-062
Brazil

Sponsor information

Coordination of Improvement of Higher Education (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior [CAPES]) (Brazil)
Government

Ministério da Educação
Anexos I e II - 2º andar
DF - Caixa Postal 365
Brasilia
70359-970
Brazil

Email dfreitas@uol.com.br
Website http://www.capes.gov.br
ROR logo "ROR" https://ror.org/00x0ma614

Funders

Funder type

Government

Coordination of Improvement of Higher Education (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior [CAPES]) (Brazil)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan